Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?


OverviewFinancialsChart

Nuvectis Pharma Ownership Summary


Nuvectis Pharma is owned by 6.09% institutional investors, 51.52% insiders, and 42.39% retail investors. Baldwin brothers llc/ma is the largest institutional shareholder, holding 2.07% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.20% of its assets in Nuvectis Pharma shares.

NVCT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNuvectis Pharma6.09%51.52%42.39%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baldwin brothers llc/ma355.96K2.07%$1.93M
Vanguard group251.14K1.52%$1.59M
Millennium management119.46K0.72%$756.17K
Blackrock83.41K0.50%$528.00K
Renaissance74.50K0.45%$471.58K
Goldman sachs group61.57K0.37%$389.74K
Forbes j m & co llp59.00K0.34%$319.19K
Geode capital management53.23K0.32%$337.00K
Northern trust49.83K0.30%$315.40K
Gsa capital partners llp48.34K0.29%$306.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Baldwin brothers llc/ma355.96K0.13%$1.93M
Forbes j m & co llp59.00K0.03%$319.19K
Gsa capital partners llp48.34K0.02%$306.00K
Baxter bros12.50K0.01%$79.13K
Nations financial group inc, /ia/ /adv13.50K0.01%$73.03K
Nbc securities5.000.00%$27.00
Edmond de rothschild19.17K0.00%$121.35K
Renaissance74.50K0.00%$471.58K
Tower research capital llc (trc)6.00K0.00%$37.95K
Millennium management119.46K0.00%$756.17K

Top Buyers

HolderShares% AssetsChange
Baldwin brothers llc/ma355.96K0.13%181.83K
Millennium management119.46K0.00%79.96K
Goldman sachs group61.57K0.00%61.57K
Citadel advisors14.94K-14.94K
Two sigma investments, lp13.04K0.00%13.04K

Top Sellers

HolderShares% AssetsChange
Blackrock83.41K--289.31K
State street15.30K--114.08K
Geode capital management53.23K--81.30K
Iridian asset management llc/ct---55.38K
Vanguard group251.14K--47.66K

New Positions

HolderShares% AssetsChangeValue
Goldman sachs group61.57K0.00%61.57K$389.74K
Citadel advisors14.94K-14.94K$94.55K
Baxter bros12.50K0.01%12.50K$79.13K
Qube research7.98K0.00%7.98K$50.50K
Macquarie group355.00-355.00$2.25K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-1.00
Nisa investment advisors-12.00
Gamma investing-25.00
Amalgamated bank-231.00
Royal bank of canada-270.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202431-18.42%1,049,389-12.85%611.52%14-44.00%11-
Jun 30, 202438-5.00%1,204,111-22.91%79.04%2513.64%11-
Mar 31, 20244011.11%1,561,9813.22%810.16%224.76%1183.33%
Dec 31, 2023369.09%1,513,31918.48%913.27%2140.00%6-53.85%
Sep 30, 202333-10.81%1,277,3041.95%811.62%15-57.14%13550.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv231.04K1.20%-
Vanguard Institutional Extnd Mkt Idx Tr81.75K0.42%-
Fidelity Extended Market Index36.91K0.19%-297.00
iShares Micro-Cap ETF21.80K0.11%-
NT R2000 Growth Index Fund - NL20.57K0.11%-
NT R2000 Index Fund - NL13.99K0.07%-5.76K
Fidelity Total Market Index13.31K0.07%-
The Vanguard Russell 2000 Growth Index12.03K0.06%-
NT R2000 Growth Index Fund - L11.40K0.06%-3.64K
Northern Trust Russell 2000 Growth Index11.40K0.06%-3.64K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 24, 2024BENTSUR RON Chairman & CEOBuy$20.93K
Dec 13, 2024Mosseri Marlio Charles-Buy$79.90K
Dec 12, 2024Mosseri Marlio Charles-Buy$149.04K
Dec 13, 2024Mosseri Marlio Charles-Buy$79.90K
Nov 19, 2024Poradosu Enrique Chief Science & Business OffBuy$9.98K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q461
2024 Q3--
2024 Q24-
2024 Q11-

NVCT Ownership FAQ


Who Owns Nuvectis Pharma?

Nuvectis Pharma shareholders are primarily institutional investors at 6.09%, followed by 51.52% insiders and 42.39% retail investors. The average institutional ownership in Nuvectis Pharma's industry, Biotech Stocks , is 109.70%, which Nuvectis Pharma falls below.

Who owns the most shares of Nuvectis Pharma?

Nuvectis Pharma’s largest shareholders are Baldwin brothers llc/ma (355.96K shares, 2.07%), Vanguard group (251.14K shares, 1.52%), and Millennium management (119.46K shares, 0.72%). Together, they hold 4.30% of Nuvectis Pharma’s total shares outstanding.

Does Blackrock own Nuvectis Pharma?

Yes, BlackRock owns 0.50% of Nuvectis Pharma, totaling 83.41K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 528K$. In the last quarter, BlackRock decreased its holdings by -289K shares, a -77.62% change.

Who is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested?

Baldwin brothers llc/ma is Nuvectis Pharma’s biggest shareholder by percentage of total assets invested, with 0.13% of its assets in 355.96K Nuvectis Pharma shares, valued at 1.93M$.

Who is the top mutual fund holder of Nuvectis Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Nuvectis Pharma shares, with 1.20% of its total shares outstanding invested in 231.04K Nuvectis Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools